WHITEHAWK THERAPEUTICS, INC. (WHWK) Operating income 2016–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) annual operating income history from SEC filings — each fiscal year as reported.
-$114.4MFY2025 · since FY2016: -$16.6M → -$114.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$114.4M | -69.6% |
| FY2024 | -$67.5M | +6.2% |
| FY2023 | -$71.9M | -14.8% |
| FY2022 | -$62.7M | +43.6% |
| FY2021 | -$111.2M | -4263.2% |
| FY2020 | -$2.5M | +89.6% |
| FY2019 | -$24.4M | -118.6% |
| FY2018 | -$11.2M | +47.7% |
| FY2017 | -$21.4M | -28.6% |
| FY2016 | -$16.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating marginWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →